BURU vs EVAX
Comparison between Nuburu Inc (BURU, Company) and Evaxion Biotech A/S (EVAX, Company).
BURU is from the Industrials sector, while EVAX is from the Healthcare sector.
BURU vs EVAX - Performance Comparison
Key Characteristics
Financial metrics and valuation ratios
Market Cap
BURU
$25M
Winner
EVAX
$25M
Max Drawdown
Winner
BURU
99.33%
EVAX
99.79%
Sharpe Ratio
BURU
-0.63
Winner
EVAX
0.85
5Y Beta
Winner
BURU
0.27
EVAX
0.77
Industry
BURU
Specialty Industrial Machinery
EVAX
Biotechnology
P/E Ratio
BURU
-0.20
Winner
EVAX
-0.42
Forward P/E
BURU
N/A
EVAX
3.57
Debt to Equity
BURU
3656.97%
Winner
EVAX
0.00%
Free Cash Flow Yield
BURU
-66.03%
Winner
EVAX
-26.17%
BURU vs EVAX - Historical Returns
Returns include dividend reinvestment.
1M
Winner
BURU
-13.15%
EVAX
-25.43%
3M
Winner
BURU
-13.42%
EVAX
-19.31%
6M
BURU
-83.97%
Winner
EVAX
-46.96%
1Y
BURU
-90.13%
Winner
EVAX
+40.55%
5Y(CAGR)
BURU
N/A
EVAX
-60.95%
Max(CAGR)
BURU
-84.06%
Winner
EVAX
-61.28%
BURU vs EVAX - Annual Returns (2021 - 2026)
Returns include dividend reinvestment.
| Year | BURU | EVAX |
|---|---|---|
| 2026 | -83.56% | -35.24% |
| 2025 | -80.10% | +3.22% |
| 2024 | -46.34% | -88.42% |
| 2023 | N/A | -60.59% |
| 2022 | N/A | -61.24% |
| 2021 | N/A | -55.31% |
BURU vs EVAX Drawdown Comparison
The maximum drawdown for BURU was -99.33%, occurring on Jun 10, 2026. This drawdown has not yet recovered.
The maximum drawdown for EVAX was -99.79%, occurring on Apr 21, 2025. This drawdown has not yet recovered.
The current BURU drawdown is -99.23%. The current EVAX drawdown is -99.52%.
| Rank | BURU | EVAX |
|---|---|---|
| #1 | -99.33% Aug 2, 2024 - Jun 10, 2026 | -99.79% Nov 4, 2021 - Apr 21, 2025 |
| #2 | -24.32% Jul 2, 2024 - Jul 30, 2024 | -47.74% Feb 8, 2021 - Nov 4, 2021 |
| #3 | -3.23% Jun 26, 2024 - Jun 28, 2024 | N/A |
Correlation
Correlation between BURU and EVAX is 0.67 which considered as a moderate positive correlation - the stocks show some tendency to move together.
0.67
-101
Select Stocks to Compare
Popular: BURU vs SPYEVAX vs SPY
More Comparisons
Compare with similar stocks